Azitra (AZTR) Current Assets (2022 - 2026)
Azitra (AZTR) reported Current Assets of $10.8 million for Q1 2026, up 177.93% on a YoY basis from $3.9 million in Q1 2025, and up 256.38% quarter-over-quarter from $3.0 million in Q4 2025.
Azitra (AZTR) Current Assets (2022 - 2026) Analysis & Trends
Azitra has reported Current Assets for 5 years, with the latest figure at $10.8 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 177.93% year-over-year to $10.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.8 million (up 177.93% YoY), and the FY2025 full-year result was $3.0 million, down 42.25% from the prior year.
- Current Assets for Q1 2026 stood at $10.8 million, up from $3.0 million in the prior quarter.
- The five-year high for Current Assets was $10.8 million in Q1 2026, with the low at $1.3 million in Q2 2024.
- Historically, Current Assets has averaged $4.4 million across 5 years, with a median of $3.9 million in 2025.
- Annual changes were most pronounced in 2024 — Current Assets plunged 80.47% — and 2026, when it jumped 177.93%.
- Azitra's Current Assets stood at $4.1 million in 2022, then plunged by 38.69% to $2.5 million in 2023, then soared by 106.2% to $5.2 million in 2024, then tumbled by 42.25% to $3.0 million in 2025, then surged by 256.38% to $10.8 million in 2026.
- The last three Current Assets figures came in at $10.8 million (Q1 2026), $3.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 10.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.76 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 5.23 Mn |
| Sep 30, 2024 | 7.63 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 2.54 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 6.84 Mn |
| Dec 31, 2022 | 4.14 Mn |